NCPIE CMI Initiative. Goals Letter of the Law –Fulfill promise of the Keystone process Spirit of the Law –Provide useful information for low literate.

Slides:



Advertisements
Similar presentations
Prescription Drug Information for Consumers and Healthcare Professionals 48 th FDLI Annual Meeting Washington, DC Wm. Ray Bullman Executive Vice President.
Advertisements

A Valuable Asset School districts put a valuable asset of the nation’s schools at risk when they ignore the health of their employees. WHY? BECAUSE… Actions.
Enhancing Written Information from the Pharmacy: An Update on MedGuides & Consumer Medicine Information (CMI) National Association of Chain Drug Stores.
Labeling Prescription Drugs for Physicians and Consumers 48 th Annual Conference Preparing for the Next Century of Food and Drug Regulation Food and Drug.
NCPIE CMI Initiative. Criteria Committee Members American Society of Health-System Pharmacists Catalina Marketing Cerner Multum First DataBank Medical.
NCPIE CMI Initiative. Education Committee Members American Pharmacists Association First DataBank National Assn. of Boards of Pharmacy National Assn.
NCPIE CMI Initiative. Implementation Cmte. Members American Society for Automation in Pharmacy Catalina Marketing Merck Research Labs National Community.
Common/shared responsibilities between jobs.
TISSUE BANKING Challenging to Say the Least
RespectAbility Conference Oct. 3-4, 2003 System-Wide Health-Care Issues for People with Disabilities Laura Remson Mitchell Legislative Coordinator Member.
The critical role of Evolving Information Systems and the need for Standardised Coding.
REMS Update NORD Corporate Council Meeting May 14, 2013
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
Health System Strengthening for Greater Health Impact Dan Kraushaar Management Sciences for Health We all say we do it and do it well, but what is it?
1. 2 Implementing and Evaluating of an Evidence Based Nursing into Practice Prepared By Dr. Nahed Said El nagger Assistant Professor of Nursing H.
UNEP Barriers to Technology Transfer - Environmentally Sound Technologies and Implementation of the Kyoto Protocol Dr Steve Halls Director International.
April 8, 2005FDLI Annual Conference 1 Labeling Prescription Drugs for Physicians and Consumers (FDA Perspective) Paul J. Seligman, MD, MPH Director, Office.
Prescription Drug Information for Patients: History
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
FDASIA REGULATIONS SUBCOMMITTEE May 22, Agenda 4:00 p.m.Call to Order – MacKenzie Robertson Office of the National Coordinator for Health Information.
Overview Community Care of North Carolina. Our Vision and Key Principles  Develop a better healthcare system for NC starting with public payers  Strong.
Marshaling Data to Improve Patient Safety Michelle Mello, JD, PhD Harvard School of Public Health.
The Autopsy Process Quality Improvement and Systems Based Practice Melissa Maricondo, DO, MPH June 2, 2009.
INTRODUCTION TO RA.
Committee Questions Design, Statistical Considerations and Study Conduct 1. There are no clear guidelines regarding the number of people that should be.
Presentation to IPU HIV/AIDS Advisory committee Mark Heywood Deputy Chairperson, SANAC.
Margarit MELIKYAN Drug Utilization Research Group PO, Armenia, National Institute of Health Access to and Use of Medicines by Households in Armenia: Impact.
FDA Risk Management Workshop: Concept Paper: Risk Management Programs April 10, 2003 Gary C. Stein, Ph.D. Director of Federal Regulatory Affairs American.
Component 16- Professionalism/Customer Service in the Health Environment Unit 8- Ethical and Cultural Issues Related to Communication and Customer Service.
Communication of Drug Safety Information Food and Drug Administration Center for Drug Evaluation & Research Public Hearing December 8, 2005.
DOING PRECONCEPTIONAL HEALTH: LOCAL REALITIES Marjorie Angert, D.O., MPH, Director of Medical Affairs, Division of Maternal, Child and Family Health, Philadelphia.
Pharmacy Intervention for Limited Literacy PILL Kara L. Jacobson, MPH, CHES Julie A. Gazmararian, PhD, MPH Sunil Kripalani, MD, MSc Karen J. McMorris,
Care Management 101 Governor's Office of Health Care Reform October 28, 2010 Cathy Gorski, RN, BS, CCM.
Risk Assessments: Patient Safety and Innovation Paul Tang, MD Keith Larsen, RPh.
Guidance Training CFR §483.75(i) F501 Medical Director.
MEDICAL SERVICE ADMINISTRATION VIETNAM MINISTRY OF HEALTH
National Public Health Performance Standards Local Assessment Instrument Essential Service:6 Enforce Laws and Regulations that Protect Health and Ensure.
Professionalism/Customer Service in the Health Environment Unit 8 Ethical and Cultural Issues Related to Communication and Customer Service Lecture 8a.
1 Presentation of the Pharmaceutical Research and Manufacturers of America at FDA Part 15 Hearing on Communication of Drug Safety Information December.
NACDD Hill Day: Legislative Visits What to Expect Mari T. Brick, MA Program Consultant, NACDD
History of FDA Consumer Information About Prescription Drugs Thomas J. McGinnis, R.Ph. July 17, 2002.
1 PRIORITY MEDICINES FOR EUROPE AND THE WORLD Barriers to Pharmaceutical Innovation Richard Laing EDM/PAR WHO.
Examining Drug Quality Regulation Douglas C. Throckmorton, MD Deputy Director Center for Drug Evaluation and Research Public Meeting on 21 CFR February,
Useful Medication Information for Consumers Gerald K. McEvoy, Pharm.D. Assistant Vice President, Drug Information Editor in Chief, AHFS Drug Information.
Elsevier items and derived items © 2009 by Saunders, an imprint of Elsevier Inc. 1 Chapter 9 Patient Teaching for Health Promotion.
Community Pharmacy in 2016 and beyond: A summary of the Pharmacy Voice response Elizabeth Wade Director of Policy, Pharmacy Voice April 2016 Slide 1 of.
Health Departments and HIV Screening Institute of Medicine Workshop 1: Screening and Access to Care April 15, 2010 Natalie Cramer, Associate Director,
MTM Medication Therapy Management. What is Medication Therapy Management? From 1996 to 2006, the number of prescription medications dispensed increased.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
References 1.Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement.
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
Professionalism/Customer Service in the Health Environment Ethical and Cultural Issues Related to Communication and Customer Service Lecture a Ethical.
Older Peoples Services/Care of the Elderly Pharmacy team: BCH Direct.
WellOne Primary Medical and Dental Care
Designing Effective Accommodation Plans in Clinical Placement & Internship Settings
State Oral Health Programs and Primary Care Agency Collaborations
2001 Healthcare Conference Keeping Health on Track
10. Overview on risk communication and new knowledge integration
Erica Takai, PhD for Andrew Farb, M.D.
WellOne Primary Medical and Dental Care
Surveillance. Public Health Approach Surveillance What is the Problem ? Problem Risk Factor Identification : What Is the Cause ? Intervention Evaluation.
NUR 431 Enthusiastic Studysnaptutorial.com
Black Box Warning What You Need To Know.
PRIVATE AND THE PUBLIC SECTORS & HEALTHCARE SERVICES BY ROBERT BASAZA
Pharmacy practice experience I
Power in communication about healthcare
Penny Fletcher MSc MRPharmS IPresc
Development of a Direct Oral Anticoagulant Monitoring Service in a Family Medicine Clinic Caprisse Honsbruch, Leah Mouw, Zachary Mulford, Jay Tieri, Sara.
Compounded Drugs and Lack of Premarket FDA-Approval
Pharmacy Benefit Manager
Presentation transcript:

NCPIE CMI Initiative

Goals Letter of the Law –Fulfill promise of the Keystone process Spirit of the Law –Provide useful information for low literate patients

NCPIE CMI Initiative Question 1 What is the private sector doing to improve the usefulness of written information regarding prescription medicines? –Much has already been done –We propose a three-function process represented by the three Committees

NCPIE CMI Initiative Process Each Committee provides essential processes, each must coordinate with the others Criteria EducationImplementation

NCPIE CMI Initiative Question 2 What barriers exist, how can they be overcome? 95% success rate is a very high standard Logistics/resources in small pharmacies –Lack of technological support How to apply Keystone criteria for certain medicines? Additional evolving barriers

NCPIE CMI Initiative Question 3 What role should FDA have? Primary –Oversight and evaluation to determine if Keystone goals are met Additional –Work with private sector to aid process –Criteria – how will FDA interpret/apply Keystone criteria –Education – share views of success and ramifications of not meeting goals –Implementation - how will FDA evaluate success?

NCPIE CMI Initiative Question 4 What other FDA initiatives are needed? –Usefulness of information for Low Literacy patients Additional interventions are needed –Research program to learn how to influence behavior –Regulatory Role Medication Guides Coordinate with risk management initiatives